USP13 and neurodegenerative disease: Conclusively, the new USP13 inhibitor BK50118-C designed by Liu et al. is the first USP13 inhibitor that can cross the blood-brain barrier, providing a powerful tool for research on USP13-related neurodegenerative diseases in the future.